HTTIF (HighTide Therapeutics) Other Current Receivables: $2.05 Mil (As of Dec. 2025)


HTTIF HighTide Therapeutics Inc HTTIF
14 GF Score
Price $0.39
! 3 Warning Signs
View Full Analysis

What is HighTide Therapeutics Other Current Receivables?

HighTide Therapeutics HTTIF 14 Other Current Receivables is $2.05 Mil as of Dec. 2025. GuruFocus rates HTTIF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

HighTide Therapeutics's Other Current Receivables for the quarter that ended in Dec. 2025 was $2.05 Mil.

HighTide Therapeutics's quarterly Other Current Receivables increased from Dec. 2024 ($0.04 Mil) to Jun. 2025 ($5.38 Mil) but then stayed the same from Jun. 2025 ($5.38 Mil) to Dec. 2025 ($2.05 Mil).

HighTide Therapeutics's annual Other Current Receivables declined from Dec. 2023 ($0.99 Mil) to Dec. 2024 ($0.04 Mil) but then increased from Dec. 2024 ($0.04 Mil) to Dec. 2025 ($2.05 Mil).

HighTide Therapeutics Other Current Receivables Related Terms

HighTide Therapeutics Other Current Receivables Historical Data

* Premium members only.

The historical data trend for HighTide Therapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HighTide Therapeutics Other Current Receivables Chart

HighTide Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
0.04 0.07 0.99 0.04 2.05

HighTide Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 0.99 4.26 0.04 5.38 2.05
HTTIF
14GF Score
HighTide Therapeutics Inc HTTIF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HighTide Therapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $2.05 Mil mean?
HighTide Therapeutics (HTTIF) has a Other Current Receivables of $2.05 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on HighTide Therapeutics and its competitors.
Is HighTide Therapeutics' Other Current Receivables too high?
HighTide Therapeutics' current Other Current Receivables is $2.05 Mil. Overall, HighTide Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does HighTide Therapeutics' Other Current Receivables compare to VRTX and REGN?
HighTide Therapeutics' Other Current Receivables of $2.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on HighTide Therapeutics and its competitors. HighTide Therapeutics's current Other Current Receivables is $2.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HighTide Therapeutics stock overvalued right now?
HighTide Therapeutics (HTTIF) has a current Other Current Receivables of $2.05 Mil. The current Other Current Receivables is $2.05 Mil. HighTide Therapeutics' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For HighTide Therapeutics (HTTIF), the current Other Current Receivables is $2.05 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HighTide Therapeutics Business Description

Other Exchanges 02511:Hong Kong
Address Fubao Street, 9th to 10th Floor, Building D, Shenfang Park, Futian District, Shenzhen-Hong Kong Science and, Technology Innovation Cooperation Zone, Guangdong, Shenzhen, CHN, 518112
HighTide Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of first-in-class multifunctional, multi-targeted therapies for cardiovascular-kidney-metabolic (CKM) diseases and related metabolic disorders. The company is developing a pipeline of proprietary drug candidates targeting indications including type 2 diabetes mellitus, chronic kidney disease, obesity, metabolic dysfunction-associated steatohepatitis (MASH), and primary sclerosing cholangitis (PSC). Its core product candidate, HTD1801 (berberine ursodeoxycholate), is an orally delivered first-in-class anti-inflammatory metabolic modulator designed to target dual pathways involving AMPK activation and NLRP3 inflammasome inhibition.
14GF Score

Get the complete analysis for HTTIF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price